Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.04M Buy
25,248
+8,523
+51% +$984K 0.91% 29
2025
Q4
$1.76M Sell
16,725
-310
-2% -$29.1K 0.64% 32
2025
Q3
$1.43M Sell
17,035
-488
-3% -$40.2K 0.53% 42
2025
Q2
$1.39M Buy
17,523
+2,989
+21% +$238K 0.44% 53
2025
Q1
$1.3M Buy
14,534
+469
+3% +$43.8K 0.47% 41
2024
Q4
$1.4M Sell
14,065
-1,182
-8% -$122K 0.51% 36
2024
Q3
$1.73M Sell
15,247
-4,653
-23% -$553K 0.58% 29
2024
Q2
$2.46M Buy
19,900
+814
+4% +$105K 0.87% 19
2024
Q1
$2.52M Sell
19,086
-733
-4% -$90.3K 0.94% 15
2023
Q4
$2.16M Buy
19,819
+712
+4% +$73.9K 0.81% 18
2023
Q3
$1.97M Sell
19,107
-349
-2% -$37.6K 0.78% 18
2023
Q2
$2.25M Sell
19,456
-387
-2% -$43.9K 0.84% 18
2023
Q1
$2.11M Sell
19,843
-229
-1% -$24.7K 0.83% 16
2022
Q4
$2.23M Buy
20,072
+697
+4% +$71.2K 0.9% 15
2022
Q3
$1.67M Sell
19,375
-2,378
-11% -$212K 0.79% 16
2022
Q2
$1.98M Sell
21,753
-2,291
-10% -$203K 0.93% 14
2022
Q1
$1.97M Sell
24,044
-535
-2% -$42.2K 0.8% 18
2021
Q4
$1.88M Sell
24,579
-2,282
-8% -$182K 0.72% 24
2021
Q3
$2.02M Buy
26,861
+9,797
+57% +$745K 0.76% 19
2021
Q2
$1.33M Buy
17,064
+1,632
+11% +$121K 0.51% 38
2021
Q1
$1.14M Sell
15,432
-125
-0.8% -$9.22K 0.48% 48
2020
Q4
$1.21M Buy
15,557
+367
+2% +$28.1K 0.51% 35
2020
Q3
$1.2M Buy
15,190
+384
+3% +$30.1K 0.64% 30
2020
Q2
$1.09M Buy
+14,806
New +$1.11M 0.97% 25

Other funds holding MRK

Prudent Man Advisors's MRK Position: Q1 2026 in Review

Prudent Man Advisors increased its Merck (MRK) stake by 51% in Q1 2026, buying an estimated $984K and bringing the position to 25,248 shares worth $3.04M. The position accounts for 0.91% of the portfolio, ranked #29.

Prudent Man Advisors first reported a position in MRK in Q2 2020 and has held it in 24 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Prudent Man Advisors held 25,248 shares of Merck worth $3.04M as of Q1 2026.
  • Prudent Man Advisors bought 8,523 Merck shares in Q1 2026, an estimated $984K.
  • Merck made up 0.91% of Prudent Man Advisors's portfolio in Q1 2026, its #29 holding.
  • Prudent Man Advisors first reported a position in Merck in Q2 2020 and has held it in 24 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Prudent Man Advisors's 13F filing for Q1 2026, filed 8 May 2026.